Corrigendum:

chemotherapy cytochrome P450 peripheral neuropathy personalised medicine pharmacogenetics

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2023
Historique:
received: 07 08 2023
accepted: 15 08 2023
medline: 18 9 2023
pubmed: 18 9 2023
entrez: 18 9 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fphar.2023.1178421.].

Identifiants

DOI: 10.3389/fphar.2023.1274075 PMID: 37719864 PMC: PMC10502220
pubmed: 37719864
doi: 10.3389/fphar.2023.1274075
pii: 1274075
pmc: PMC10502220
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1274075

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 McEvoy, Cliff, Carr, Jorgensen, Lord and Pirmohamed.

Auteurs

Laurence McEvoy (L)

Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.

Joanne Cliff (J)

Clatterbridge Cancer Centre, Liverpool, United Kingdom.

Daniel F Carr (DF)

Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.

Andrea Jorgensen (A)

Health Data Science, University of Liverpool, Liverpool, United Kingdom.

Rosemary Lord (R)

Clatterbridge Cancer Centre, Liverpool, United Kingdom.

Munir Pirmohamed (M)

Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.

Classifications MeSH